PTC Therapeutics | Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amgen USD 5.9B 773M 2025-12
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Cytokinetics USD 168.69M 9.58M 2025-09
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Novartis USD 9.86B 115M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Puma Biotechnology USD 49.26M 3.2M 2024-06
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
TG Therapeutics USD 132.34M 26.04M 2025-09
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Xencor USD 68.52M 8.26M 2025-09


PTC Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.